Association between the Stress Hyperglycemia Ratio Index and Short-term All-cause Mortality as well as ICU All-cause Mortality in Heart Failure Patients Receiving Invasive Ventilation: A Retrospective Study Based on the MIMIC-IV Database
Article Sidebar
Main Article Content
Abstract
Background: The stress-induced hyperglycemic ratio (SHR) is an index that reflects the imbalance between acute stress-induced glucose fluctuations and baseline glucose metabolism levels. Currently, there are few studies on the SHR index and its prognostic significance in heart failure (HF) patients undergoing invasive mechanical ventilation. This study aimed to investigate the relationship of SHR with the risk of death in HF patients requiring invasive ventilation.
Methods: Conduct a retrospective cohort study based on the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Include adult heart failure patients who received invasive ventilation and divide them into quartile groups according to the level of the Systemic Heart Rate (SHR). The primary endpoints of the observation are the 30-day all-cause mortality rate and the all-cause mortality rate in the Intensive Care Unit (ICU), while the secondary endpoints are the 365-day all-cause mortality rate and the all-cause mortality rate during hospitalization. The Kaplan-Meier curve is used to compare the survival outcomes between groups. A Cox proportional hazards regression model that adjusts for demographic characteristics, underlying diseases, and the severity of critical illnesses is employed to evaluate the relationship between SHR and the mortality rate. The Restricted Cubic Spline (RCS) is utilized to test the nonlinear association between the two, and subgroup analysis is carried out to verify the consistency of the results across different groups.
Results: Among the 1,038 eligible patients, the mean age was 68.50 years (range: 59.46 - 77.48 years), and 639 (61.56%) of them were male. The Kaplan-Meier curve showed that the higher the SHR index, the higher the risk of all-cause mortality in patients at 30 days (log-rank test, p = 0.011) and in the ICU (log-rank test, p = 0.0029). An increase in SHR was independently associated with an increased risk of 30-day and ICU mortality. Compared with the second quartile group Q2, the 30-day mortality rate in the group with the highest SHR was significantly higher (HR = 1.59, 95% CI 1.08, 2.33), and the ICU mortality rate in the group with the highest SHR was significantly higher (HR = 1.86, 95% CI 1.10, 3.14). The restricted cubic spline analysis showed a non-linear dose-response relationship between SHR and 30-day all-cause mortality (p for non-linearity < 0.05), and the risk of 30-day and ICU all-cause mortality gradually increased with the increase of the SHR index. The risks of 30-day and all-cause mortality in the ICU gradually increased. The results of the subgroup analysis confirmed that it remained stable in the subgroup of patients with Coronary Heart Disease (CHD).
Conclusion: In critically ill heart failure (HF) patients receiving invasive ventilation, a higher stress hyperglycemia ratio (SHR) index is significantly associated with an increased risk of 30-day and all-cause mortality in the intensive care unit (ICU). Meanwhile, the SHR index is an independent predictor of mortality in critically ill HF patients who require invasive ventilation.
Article Details
Copyright (c) 2015 Zhu P, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced heart failure epidemiology and outcomes: a population-based study. JACC Heart Fail. 2021;9(10):722-732. Available from: https://www.sciencedirect.com/science/article/pii/S2213177921002253
2. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272-3287. Available from: https://academic.oup.com/cardiovascres/article/118/17/3272/6522620
3. Saijo T, Yasumoto K, Ohashi M, Momoki C, Habu D. Association between early enteral nutrition and clinical outcome in patients with severe acute heart failure who require invasive mechanical ventilation. JPEN J Parenter Enteral Nutr. 2022;46(3):443-453. Available from: https://onlinelibrary.wiley.com/doi/10.1002/jpen.2118
4. Tavazzi G. Mechanical ventilation in cardiogenic shock. Curr Opin Crit Care. 2021;27(5):447-453. Available from: https://journals.lww.com/co-criticalcare/Abstract/2021/10000/Mechanical_ventilation_in_cardiogenic_shock.10.aspx
5. Liu J, Zhou Y, Huang H, Liu R, Kang Y, Zhu T, et al. Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from American MIMIC-IV and the Chinese CIN-II study. Cardiovasc Diabetol. 2023;22:281. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-02012-1
6. Yan F, Chen X, Quan X, Wang L, Wei X, Zhu J. Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning. Cardiovasc Diabetol. 2024;23:163. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02265-4
7. Zhang Y, Yin X, Liu T, Ji W, Wang G. Association between the stress hyperglycemia ratio and mortality in patients with acute ischemic stroke. Sci Rep. 2024;14:20962. Available from: https://www.nature.com/articles/s41598-024-71778-5
8. Esposito K, Marfella R, Giugliano D. Stress hyperglycemia, inflammation, and cardiovascular events. Diabetes Care. 2003;26(5):1650-1651. Available from: https://diabetesjournals.org/care/article/26/5/1650-a/26582
9. Li L, Ding L, Zheng L, Wu L, Hu Z, Liu L, et al. Relationship between stress hyperglycemia ratio and acute kidney injury in patients with congestive heart failure. Cardiovasc Diabetol. 2024;23:29. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-02105-x
10. Li L, Zhao Z, Wang S, Wang J. Stress hyperglycemia ratio and the clinical outcome of patients with heart failure: a meta-analysis. Front Endocrinol (Lausanne). 2024;15:1404028. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2024.1404028
11. Huang J, Yin H, Zhang M, Ni Q, Xuan J. Understanding the economic burden of heart failure in China: impact on disease management and resource utilization. J Med Econ. 2017;20:549–553. Available from: https://www.tandfonline.com/doi/full/10.1080/13696998.2017.1297309
12. Singh A, Laribi S, Teerlink JR, Mebazaa A. Agents with vasodilator properties in acute heart failure. Eur Heart J. 2017;38:317–325. Available from: https://academic.oup.com/eurheartj/article/38/5/317/1744389
13. Alviar CL, Miller PE, McAreavey D, Katz JN, Lee B, Moriyama B, et al. Positive pressure ventilation in the cardiac intensive care unit. J Am Coll Cardiol. 2018;72:1532–1553. Available from: https://www.sciencedirect.com/science/article/pii/S0735109718385029
14. Metkus TS, Stephens RS, Schulman S, Hsu S, Morrow DA, Eid SM. Utilization and outcomes of early respiratory support in 6.5 million acute heart failure hospitalizations. Eur Heart J Qual Care Clin Outcomes. 2020;6:72–80. Available from: https://academic.oup.com/ehjqcco/article/6/1/72/5552672
15. Miyama H, Shiraishi Y, Kohsaka S, Goda A, Nishihata Y, Nagatomo Y, et al. Abnormal liver function tests and long-term outcomes in patients discharged after acute heart failure. J Clin Med. 2021;10:1730. Available from: https://www.mdpi.com/2077-0383/10/8/1730
16. Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016;12:610–623. Available from: https://www.nature.com/articles/nrneph.2016.113
17. Lapinsky SE. Endotracheal intubation in the ICU. Crit Care. 2015;19:258. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0964-z
18. Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries. JAMA. 2021;325:1164–1172. Available from: https://jamanetwork.com/journals/jama/fullarticle/2777394
19. Zhang S, Guo M, Wu F, Xiong N, Ma Y, Wang Z, et al. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study. Clin Microbiol Infect. 2020;26:1670–1675. Available from: https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30536-4/fulltext
20. Li L, Zhao Z, Wang S, Wang J. Stress hyperglycemia ratio and the clinical outcome of patients with heart failure: a meta-analysis. Front Endocrinol (Lausanne). 2024;15:1404028. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2024.1404028
21. Yan F, Chen X, Quan X, Wang L, Wei X, Zhu J. Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning. Cardiovasc Diabetol. 2024;23:163. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02265-4
22. Zhang C, Shen HC, Liang WR, Ning M, Wang ZX, Chen Y, et al. Relationship between stress hyperglycemia ratio and all-cause mortality in critically ill patients: results from the MIMIC-IV database. Front Endocrinol (Lausanne). 2023;14:1111026. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2023.1111026
23. Tian J, Zhou T, Liu Z, Dong Y, Xu H. Stress hyperglycemia is associated with poor prognosis in critically ill patients with cardiogenic shock. Front Endocrinol (Lausanne). 2024;15:1446714. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2024.1446714
24. Matias AA, Manique I, Sabino T, Rego T, Mihon C, Panarra A, et al. Absolute hyperglycemia versus stress hyperglycemia ratio for the prognosis of hospitalized patients with COVID-19 in the first months of the pandemic: a retrospective study. Diabetes Ther. 2023;14:335–346. Available from: https://link.springer.com/article/10.1007/s13300-022-01347-4
25. Su YW, Hsu CY, Guo YW, Chen HS. Usefulness of the plasma glucose concentration-to-HbA1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. 2017;43:40–47. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1262363616302152
26. Barbu E, Mihaila A, Filippi A, Stoenescu A, Ciortan L, Butoi E, et al. Stress, hyperglycemia, and insulin resistance correlate with neutrophil activity and impact acute myocardial infarction outcomes. Cureus. 2024;16:e63731. Available from: https://www.cureus.com/articles/261137-stress-hyperglycemia-and-insulin-resistance-corroborate-with-neutrophil-activity-and-impact-acute-myocardial-infarction-outcomes
27. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53:298–304. Available from: https://www.jacc.org/doi/full/10.1161/circulationaha.108.191305
28. Denorme F, Portier I, Kosaka Y, Campbell RA. Hyperglycemia exacerbates ischemic stroke outcome independent of platelet glucose uptake. J Thromb Haemost. 2021;19:536–546. Available from: https://onlinelibrary.wiley.com/doi/10.1111/jth.15154
29. Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis EA, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 2001;38:71–76. Available from: https://link.springer.com/article/10.1007/s005920170016
30. Sonsoz MR, Karadamar N, Yilmaz HC, Eroglu Z, Sahin KK, Ozates Y, et al. C-reactive protein to albumin ratio predicts in-hospital mortality in patients with acute heart failure. Turk Kardiyol Dern Ars. 2023;51:174–181. Available from: https://tkddergisi.org/abstract.php?id=3981
31. Lin Z, Liang X, Zhang Y, Dai Y, Zeng L, Chen W, et al. Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22:76. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01799-3
32. Krebs ED, Chancellor WZ, Beller JP, Mehaffey JH, Hawkins RB, Sawyer RG, et al. Long-term implications of tracheostomy in cardiac surgery patients: decannulation and mortality. Ann Thorac Surg. 2021;111:594–599. Available from: https://www.annalsthoracicsurgery.org/article/S0003-4975(20)31161-4/fulltext
33. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuniga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:122. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-018-0762-4
34. Ding L, Zhang H, Dai C, Zhang A, Yu F, Mi L, et al. The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018. Cardiovasc Diabetol. 2024;23:84. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02172-8
35. Liao W, Chen Y, Gao Q, Gan R, Li M, Liu Z, et al. Impact of stress hyperglycemia ratio, derived from glycated albumin or hemoglobin A1c, on mortality among ST-segment elevation myocardial infarction patients. Cardiovasc Diabetol. 2023;22:334. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-02061-6
36. Barbu E, Mihaila A, Filippi A, Stoenescu A, Ciortan L, Butoi E, et al. Stress, hyperglycemia, and insulin resistance correlate with neutrophil activity and impact acute myocardial infarction outcomes. Cureus. 2024;16:e63731. Available from: https://www.cureus.com/articles/261137-stress-hyperglycemia-and-insulin-resistance-corroborate-with-neutrophil-activity-and-impact-acute-myocardial-infarction-outcomes
37. Motoyama S. C-reactive protein -717C>T genetic polymorphism associates with esophagectomy-induced stress hyperglycemia. World J Surg. 2010;34:1001–1007.
38. Olesen OJ, Vinding NE, Østergaard L, Butt JH, Gislason GH, Torp-Pedersen C, et al. C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation. Europace. 2020;22:1182–1188. Available from: https://academic.oup.com/europace/article/22/8/1182/5893503
39. Wu Z, Cheng C, Sun X, Wang J, Guo D, Chen S, et al. The synergistic effect of the triglyceride-glucose index and serum uric acid on the prediction of major adverse cardiovascular events after coronary artery bypass grafting: a multicenter retrospective cohort study. Cardiovasc Diabetol. 2023;22:103. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-023-01838-z
40. Kerby JD, Griffin RL, MacLennan P, Rue LW. Stress-induced hyperglycemia, not diabetic hyperglycemia, is associated with higher mortality in trauma. Ann Surg. 2012;256:446–452.
41. Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X, et al. Adipokines, hepatokines, and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation. Front Endocrinol (Lausanne). 2022;13:873699. Available from: https://www.frontiersin.org/articles/10.3389/fendo.2022.873699
42. Yan F, Chen X, Quan X, Wang L, Wei X, Zhu J. Association between the stress hyperglycemia ratio and 28-day all-cause mortality in critically ill patients with sepsis: a retrospective cohort study and predictive model establishment based on machine learning. Cardiovasc Diabetol. 2024;23:163. Available from: https://cardiab.biomedcentral.com/articles/10.1186/s12933-024-02265-4
43. Fujimura N, Noma K, Hata T, Soga J, Hidaka T, Idei N, et al. Mineralocorticoid receptor blocker eplerenone improves endothelial function and inhibits rho-associated kinase activity in patients with hypertension. Clin Pharmacol Ther. 2012;91:289–297. Available from: https://www.nature.com/articles/clpt2011227